News & Trends - MedTech & Diagnostics
‘Parachutes’ make cardiac surgery safer
MedTech News: A novel blood filtering device has added a new layer of safety to heart surgery.
While advancements such as TAVI (Transcatheter Aortic Valve Implantation) have provided minimally-invasive alternatives to open-heart procedures, some patients are still at risk of post-surgery strokes.
TAVI operations to treat severe aortic stenosis sometimes result in pieces of calcified heart valve or other debris breaking loose and travelling to the brain, blocking blood flow.
However, surgeons at Sydney Adventist Hospital have started using an anti-stroke protection device that acts as a safety net during TAVI procedures to free up such narrowed valves.
Boston Scientific’s Sentinel Cerebral Protection System is designed to capture embolic debris dislodged before it can reach the brain.
The filters are attached to a wire, inserted into the valves and inflated to provide a barrier to solid objects in the blood.
“These devices are like little parachutes with very fine mesh that allow blood flow, but these nets catch any clots or calcium or tissue that is liberated during the new valve implantation,” said cardiothoracic specialist Dr Brian Plunkett.
Dr Plunkett is one of several surgeons at the hospital using the new filter system, which he said is another step in over 10 years of evolution in TAVI-related technology.
“Many patients are mobile and active, and stroke would be a major risk to them,” he added.
“We are all excited at the prospect of adding anything to our armoury to reduce stroke risk in any TAVI deployment.”
News & Trends - Pharmaceuticals
Federal Health Minister succumbs to pressure, commits to extra meeting to clear PBAC backlog
Pharma News: The Minister for Health and Aged Care, Mark Butler MP, has confirmed that the Pharmaceutical Benefits Advisory Committee […]
MoreNews & Trends - MedTech & Diagnostics
Medtech company partners with Aussie researchers in AI technology for GI cancer detection
MedTech & Diagnostics News: To develop a next-generation gastrointestinal (GI) flexible endomicroscope equipped with edge-artificial intelligence (AI) technology, Monash University’s […]
MoreNews & Trends - Pharmaceuticals
Local oncologists first to enrol prostate cancer patients in phase 3 theranostics trial
Pharma News: GenesisCare oncologists have achieved a significant milestone, becoming the first to enrol and deliver patient treatment in a […]
MoreHuman Resources
Ipsen’s culture of ‘collaboration and diversity’ earns Great Place to Work certification
Ipsen Australia and New Zealand has announced its certification as a Great Place to Work in 2024, joining 11 other […]
More